Metropolitan Life Insurance CO Brainstorm Cell Therapeutics Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$3.99 - $17.73 $36,257 - $161,112
-9,087 Closed
0 $0
Q3 2020

Jun 26, 2023
BUY
$11.19 - $16.92 $101,683 - $153,752
9,087 New
9,087 $153,000
Q2 2020

Jun 26, 2023
BUY
$4.42 - $12.66 $40,164 - $115,041
9,087 New
9,087 $101,000
Q2 2020

Mar 30, 2023
BUY
$4.42 - $12.66 $40,164 - $115,041
9,087 New
9,087 $101,000
Q2 2020

Aug 14, 2020
BUY
$4.42 - $12.66 $40,164 - $115,041
9,087 New
9,087 $102,000

Others Institutions Holding BCLI

# of Institutions
42
Shares Held
10.9M
Call Options Held
160K
Put Options Held
30.5K
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $39.4M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email